
Loss of son spurs Yorkton couple to raise $1.5 million for cancer-fighting efforts
CBC's virtual road trip series Land of Living Stories explores the hidden gems across Saskatchewan. Reporter Janani Whitfield hit the road to Yorkton in search of inspiring stories of community spirit. This is the third story in a three-part series from that community.
In their darkest times as a family, the Ottenbreits have held on to a saying. It helped them through the loss of their child to cancer, and in their work to rally people in Yorkton, Sask., and beyond to join them in a fight against the insidious disease.
Greg Ottenbreit remembers its origin well. He was looking at his son Brayden, sedated on a gurney in a hospital and waiting for a scan. Brayden was three years old when he was diagnosed with ganglioneuroblastoma, the cancer that would later claim his young life.
"You always go to a dark place. In my mind, I had his funeral 10 times," Greg said, turning to look at his wife, Leone. "And that's when Leone says, 'You know what, no matter what happens, we've got to choose to be better, not bitter…. No matter what happens, we've gotta make a conscious effort. This isn't gonna tear us apart and our family apart.'"
At the time, they didn't know what lay ahead — the grief that comes from losing a child and the strain it can put on a family. They also didn't know his death would drive them to start an event that's still going strong and has raised more than $1.5 million for cancer research and support initiatives.
In 1998, family and friends shaved their heads in solidarity with Brayden, with the local Kinsman Club encouraging them, and raised $14,000. The event stuck, gaining even more support from the community after Brayden's death in February 2000.
"When you lose a child, it's like, what are you going to do with that? Myself, what I wanted to do was curl up in the corner," Leone said.
When she sees people benefiting from their fundraising efforts, she feels driven to continue.
"It actually puts a purpose to our pain."
Beyond the now-annual Brayden Ottenbreit Close Cuts for Cancer event, the couple has helped spur other fundraising events like pancake breakfasts and hot dog sales. Greg, a former Sask. Party MLA, even sported a mullet in the legislature to raise funds. All the money has gone to cancer-related causes, such as funding family stays at the Ronald McDonald house in Saskatoon, a medically-assisted camp for children who've been affected by cancer or renovations at the Saskatoon Cancer Patient Lodge.
It's all done in memory of a boy whose parents recall him as "a character," who brought smiles to the hospital staff by using a squeaky tricycle instead of a wheelchair to get around the hospital, or challenge volunteers at the cancer clinic to races.
Leone brings up her Facebook profile to show her son's picture, frozen in the year 1999, forever a child, kissing his mother's cheek. It remains her favourite photo of all time.
"[This] is him hugging me after we both shaved our heads. You can just sense the love."
Leone said she knows Brayden would be thrilled with the efforts he's inspired in his family and across the province, nearly three decades after his death.
"We're quite certain that he's still cheering us on from heaven going, 'Yeah, you guys just keep going. This is awesome.'"
It's the good memories that stay with them and gives them the strength to support other cancer patients and their families, Leone said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBC
36 minutes ago
- CBC
B.C. pulls funding on $1M drug for 9-year-old Vancouver Island girl with rare condition
The B.C. government said Wednesday it will be pulling funding for an extremely expensive drug used by one person in the province — a young Vancouver Island girl. Charleigh Pollock, 9, suffers from neuronal ceroid lipofuscinosis type 2, also known as CLN2 or Batten disease, a rare and terminal genetic disorder that causes multiple seizures every day, eventually causing brain damage. Pollock's name became known in 2019 when the province announced it would be covering the cost of a $1 million-per-year medication for her known as Brineura, which is given through an infusion of fluid to the brain to slow the progression of CLN2. Pollock is the only person in B.C. with the disease, which has no cure. "Expensive drugs for rare diseases add a layer of complexity to decision-making," Health Minister Josie Osborne said in a statement on Wednesday. However, she said, the cost of the medication has nothing to do with the recommendations made by medical experts that made this decision to stop coverage. Funding for the drug was approved when Pollock was three years old. Osborne said once a patient has declined in their motor and language functions by a certain amount, Brineura no longer slows the progression of CLN2. "Last year, it was determined that Charleigh's condition had progressed to the point where she met the discontinuation criteria for Brineura," she said. From there, she said the ministry undertook a review of the situation. The province said the decision to cover drugs for patients that fall under B.C.'s Expensive Drugs for Rare Diseases program are made based on recommendations from a committee of independent experts that use clinical criteria from by Canada's Drug Agency. "I know this is not what Charleigh's family wanted to hear. It's not what any of us wanted to hear," Osborne said. In a Facebook post made on June 13 prior to the decision being made, Pollock's mother Jori Fales said that after reading the Drug Agency's report, she couldn't see how the B.C. government would choose to stop coverage. She said Pollock's medical team feels continuing the medication is in her best interest. "Anything less is simply cruel and wrong," she wrote.


CTV News
43 minutes ago
- CTV News
AHS warns of blue-green algae at Elk Island
Alberta Health Services (AHS) is warning visitors to Elk Island National Park of blue-green algae seen in the waters of Astotin Lake. The health authority said to avoid all contact with blue-green algae blooms and to wash with tap water as soon as possible if contact occurs. Do not swim or allow pets to swim or wade in areas where the algae is visible. Consider limiting human consumption of whole fish or fish trimmings from the lake. Do not feed any fish or fish trimmings to pets. Fish filets from the lake are safe for humans to eat. Blue-green algae, also known as cyanobacteria, can look like scum, grass clippings, fuzz or globs on the surface water. It can be blue-green, greenish-brown, brown and/or pinkish-red, and often smell musty or grassy. Blue-green algae Blue-green algae is seen near the shore in this undated photo. (Courtesy: Grand River Conservation Authority/ Skin irritation, rash, sore throat, sore red eyes, swollen lips, fever, nausea and vomiting and/or diarrhea can occur when exposed to blue-green algae or by consuming water containing the bacteria. Exposure to blue-green algae can cause death to pets. Waters of Astotin Lake that do not have visible blue-green algae can still be used for recreational purposes.


CTV News
an hour ago
- CTV News
Much Ado About Nothing: The original rom-com gets a 21st century makeover
The Shakespeare Company and Full Circle Theatre team up to present Much Ado About Nothing at the West Village Theatre through June 28. Much Ado About Nothing might not be the original romantic comedy, but if's got to be close. The comedy which tells the story of the relationship between Beatrice and Benedick, is thought to have been written around 1598, before daily newspapers -- and theatre critics -- even existed. Talk about a word-of-mouth hit! Now, Calgary's Shakespeare Company is teaming up with Full Circle Theatre to present a new, 21st century production of the romantic comedy that inspired such contemporary Hollywood hits as Anyone But You, the 2024 film starring Sydney Sweeney and Glen Powell. It's a follow-up of sorts to past Full Circle productions such as Riverona, which was a teen drama adaptation of Romeo and Juliet by Full Circle, a Calgary independent theatre company launched in 2010 by Erin Weir and Claire Bolton, a pair of U of C graduates. The company, a collective that celebrates women in theatre, is teaming up with The Shakespeare Company, whose artistic director Richard Beaune is returning to the stage in Much Ado to play Dogberry. 'Both companies are committed to approachable, emotionally grounded Shakespeare that feels real and relevant to today's audiences,' Weir said in a media release. As for Much Ado, the themes of a 16th century romance will be recognizable to a 21st century audience, Weir says. 'At the heart of this production is an exploration of trust,' she said. 'How it's built, how it's broken, and what it costs us. As love stories unravel and friendships are tested, the audience is asked: what does it mean to truly believe in someone?' Much Ado About Nothing runs through June 28 at West Village Theatre. For more information, go here or here.